YINasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends December 31
111, Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$3.13+0.00 (+0.16%)
Close on Oct 19, 2026
111 statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Retail-Drug Stores and Proprietary Stores companies for comparison
Income (trailing twelve months)
| Measure | 111 | Industry median |
|---|---|---|
| Revenue | CN¥12.56B | CN¥6.34B |
| Gross Profit | CN¥723.41M | CN¥723.41M |
| Operating Income | -CN¥2.38M | CN¥56.56M |
| Pretax Income | -CN¥22.50M | -CN¥852.00K |
| EBITDA | CN¥9.46M | CN¥229.22M |
| EPS (Diluted) | -0.38 CNY | -0.21 CNY |
Margins
| Measure | 111 | Industry median |
|---|---|---|
| Gross Margin | 5.76% | 26.3% |
| Operating Margin | -0.02% | 0.10% |
| Pretax Margin | -0.18% | -0.19% |
| EBITDA Margin | 0.08% | 0.51% |
| FCF Margin | 0.91% | 0.91% |
Returns
| Measure | 111 | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -0.96% | 0.94% |
Growth
| Measure | 111 | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -12.8% | -6.32% |
| FCF Growth (YoY) | -53.7% | -55.3% |
| Revenue Growth (3Y CAGR) | -2.43% | 0.19% |
| Revenue Growth (5Y CAGR) | 8.89% | 1.57% |
Balance sheet
| Measure | 111 | Industry median |
|---|---|---|
| Cash & Short-Term Investments | CN¥561.00M | CN¥873.02M |
| Total Debt | CN¥187.63M | CN¥255.24M |
| Net Cash (Debt) | CN¥373.37M | CN¥861.92M |
| Net Cash Per Share | 1.06 CNY | 5.26 CNY |
| Equity (Book Value) | -CN¥702.23M | CN¥988.01M |
| Book Value Per Share | -2.00 CNY | 7.69 CNY |
| Tangible Book Value | -CN¥703.10M | CN¥903.00M |
| Working Capital | CN¥171.18M | CN¥245.52M |
Financial position
| Measure | 111 | Industry median |
|---|---|---|
| Current Ratio | 1.09 | 1.28 |
| Quick Ratio | 0.42 | 0.87 |
| Debt / EBITDA | 19.83 | 0.90 |
| Debt / FCF | 1.64 | 1.35 |
| Net Debt / EBITDA | -39.46 | -5.20 |
| Interest Coverage | -0.07 | 0.99 |
Cash flow (trailing twelve months)
| Measure | 111 | Industry median |
|---|---|---|
| Operating Cash Flow | CN¥119.14M | CN¥119.14M |
| Capital Expenditures | -CN¥4.45M | -CN¥87.67M |
| Free Cash Flow | CN¥114.69M | CN¥147.74M |
| FCF Per Share | 0.33 CNY | 0.61 CNY |
Efficiency
| Measure | 111 | Industry median |
|---|---|---|
| Asset Turnover | 5.03 | 1.57 |
| Inventory Turnover | 9.92 | 10.91 |
| Revenue Per Employee | CN¥87.19M | CN¥6.99M |
| Employee Count | 144 | 2,006 |
Shares
| Measure | 111 | Industry median |
|---|---|---|
| Shares Outstanding | 351,405,000 | 348,633,000 |
| Shares Change (YoY) | 1.27% | 0.25% |
| Float | 274,965,000 | 200,361,500 |
| Shares Held by Insiders | 21.8% | 20.1% |
| Shares Held by Institutions | 0.01% | 3.64% |
Taxes
| Measure | 111 | Industry median |
|---|---|---|
| Income Tax | CN¥13.00K | CN¥9.16M |
Scores
| Measure | 111 | Industry median |
|---|---|---|
| Beneish M-Score | -3.31 |
Calculated by StockData from 111's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.